Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia results from the SPIRE randomized trials of bococizumab
Paul M. Ridker Raul Dias dos Santos Filho; Lynda M Rose; John J. P Kastelein; Caimiao Wei; James Revkin; Carla YUNIS; Jean-Claude Tardif; Charles L Shear
Journal of clinical lipidology v. 12, n. 4, p. 958-965, 2018New York 2018
Localização: FM - Fac. Medicina (OPI 29397 2018 )(Acessar)
- 0
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
opi 29418 2018
opi 29355 2018
browse_callnumber
display.do?vl(4708289UI0)=creator&gathStatTab=true&dscnt=0&callNumberBrowseField=browse_callnumber&mode=Basic&tabRealType=browseshelf&vid=USP&rfnGrp=1&tab=default_tab&vl(56004861UI1)=all_items&dstmp=1721896615339&rfnGrpCounter=1&scp.scps=scope%3A%28USP_VIDEOS%29%2Cscope%3A%28%22PRIMO%22%29%2Cscope%3A%28USP_FISICO%29%2Cscope%3A%28USP_EREVISTAS%29%2Cscope%3A%28USP%29%2Cscope%3A%28USP_EBOOKS%29%2Cscope%3A%28USP_PRODUCAO%29%2Cprimo_central_multiple_fe&fctV=Hipercolesterolemia&callNumber=opi+29397+2018&fctN=facet_topic&vl(freeText0)=Dias%20Filho%2C%20J&ct=display&fn=search&indx=8&recIdxs=0&elementId=0